Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15448205rdf:typepubmed:Citationlld:pubmed
pubmed-article:15448205lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:15448205lifeskim:mentionsumls-concept:C0038250lld:lifeskim
pubmed-article:15448205lifeskim:mentionsumls-concept:C0027022lld:lifeskim
pubmed-article:15448205lifeskim:mentionsumls-concept:C0206454lld:lifeskim
pubmed-article:15448205lifeskim:mentionsumls-concept:C0080347lld:lifeskim
pubmed-article:15448205lifeskim:mentionsumls-concept:C0033681lld:lifeskim
pubmed-article:15448205lifeskim:mentionsumls-concept:C0205177lld:lifeskim
pubmed-article:15448205lifeskim:mentionsumls-concept:C0332466lld:lifeskim
pubmed-article:15448205lifeskim:mentionsumls-concept:C0915830lld:lifeskim
pubmed-article:15448205pubmed:issue40lld:pubmed
pubmed-article:15448205pubmed:dateCreated2004-10-7lld:pubmed
pubmed-article:15448205pubmed:abstractTextHuman stem cell leukemia-lymphoma syndrome usually presents itself as a myeloproliferative disorder (MPD) that evolves to acute myeloid leukemia and/or lymphoma. The syndrome associated with t(8;13)(p11;q12) results in expression of the ZNF198-fibroblast growth factor receptor (FGFR) 1 fusion tyrosine kinase. Current empirically derived cytotoxic chemotherapy is inadequate for treatment of this disease. We hypothesized that small-molecule inhibitors of the ZNF198-FGFR1 fusion would have therapeutic efficacy. We characterized the transforming activity of ZNF198-FGFR1 in hematopoietic cells in vitro and in vivo. Expression of ZNF198-FGFR1 in primary murine hematopoietic cells caused a myeloproliferative syndrome in mice that recapitulated the human MPD phenotype. Transformation in these assays, and activation of the downstream effector molecules PLC-gamma, STAT5, and phosphatidylinositol 3-kinase/AKT, required the proline-rich domains, but not the ZNF domains, of ZNF198. A small-molecule tyrosine kinase inhibitor, PKC412 (N-benzoyl-staurosporine) effectively inhibited ZNF198-FGFR1 tyrosine kinase activity and activation of downstream effector pathways, and inhibited proliferation of ZNF198-FGFR1 transformed Ba/F3 cells. Furthermore, treatment with PKC412 resulted in statistically significant prolongation of survival in the murine model of ZNF198-FGFR1-induced MPD. Based in part on these data, PKC412 was administered to a patient with t(8;13)(p11;q12) and was efficacious in treatment of progressive myeloproliferative disorder with organomegaly. Therefore, PKC412 may be a useful therapy for treatment of human stem cell leukemia-lymphoma syndrome.lld:pubmed
pubmed-article:15448205pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15448205pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15448205pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15448205pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15448205pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15448205pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15448205pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15448205pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15448205pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15448205pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15448205pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15448205pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15448205pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15448205pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15448205pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15448205pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15448205pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15448205pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15448205pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15448205pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15448205pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15448205pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15448205pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15448205pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15448205pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15448205pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15448205pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15448205pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15448205pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15448205pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15448205pubmed:languageenglld:pubmed
pubmed-article:15448205pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15448205pubmed:citationSubsetIMlld:pubmed
pubmed-article:15448205pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15448205pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15448205pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15448205pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15448205pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15448205pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15448205pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15448205pubmed:statusMEDLINElld:pubmed
pubmed-article:15448205pubmed:monthOctlld:pubmed
pubmed-article:15448205pubmed:issn0027-8424lld:pubmed
pubmed-article:15448205pubmed:authorpubmed-author:MeyerThomasTlld:pubmed
pubmed-article:15448205pubmed:authorpubmed-author:ChenJingJlld:pubmed
pubmed-article:15448205pubmed:authorpubmed-author:WilliamsIfor...lld:pubmed
pubmed-article:15448205pubmed:authorpubmed-author:GillilandD...lld:pubmed
pubmed-article:15448205pubmed:authorpubmed-author:GriffinJames...lld:pubmed
pubmed-article:15448205pubmed:authorpubmed-author:KutokJeffery...lld:pubmed
pubmed-article:15448205pubmed:authorpubmed-author:StoneRichard...lld:pubmed
pubmed-article:15448205pubmed:authorpubmed-author:FletcherJonat...lld:pubmed
pubmed-article:15448205pubmed:authorpubmed-author:LeeBenjamin...lld:pubmed
pubmed-article:15448205pubmed:authorpubmed-author:FabbroDoriano...lld:pubmed
pubmed-article:15448205pubmed:authorpubmed-author:DuclosNicoleNlld:pubmed
pubmed-article:15448205pubmed:authorpubmed-author:XiaoShengSlld:pubmed
pubmed-article:15448205pubmed:authorpubmed-author:CohenSarahSlld:pubmed
pubmed-article:15448205pubmed:authorpubmed-author:HuntlyBrianBlld:pubmed
pubmed-article:15448205pubmed:authorpubmed-author:GalinskyIlene...lld:pubmed
pubmed-article:15448205pubmed:authorpubmed-author:BanerjiLolita...lld:pubmed
pubmed-article:15448205pubmed:authorpubmed-author:WadleighMarth...lld:pubmed
pubmed-article:15448205pubmed:authorpubmed-author:DeangeloDanie...lld:pubmed
pubmed-article:15448205pubmed:authorpubmed-author:CohenPamela...lld:pubmed
pubmed-article:15448205pubmed:authorpubmed-author:RoeselJohanne...lld:pubmed
pubmed-article:15448205pubmed:authorpubmed-author:AdelspergerJe...lld:pubmed
pubmed-article:15448205pubmed:authorpubmed-author:OkabeRachelRlld:pubmed
pubmed-article:15448205pubmed:authorpubmed-author:CoburnAllison...lld:pubmed
pubmed-article:15448205pubmed:issnTypePrintlld:pubmed
pubmed-article:15448205pubmed:day5lld:pubmed
pubmed-article:15448205pubmed:volume101lld:pubmed
pubmed-article:15448205pubmed:ownerNLMlld:pubmed
pubmed-article:15448205pubmed:authorsCompleteYlld:pubmed
pubmed-article:15448205pubmed:pagination14479-84lld:pubmed
pubmed-article:15448205pubmed:dateRevised2010-5-26lld:pubmed
pubmed-article:15448205pubmed:meshHeadingpubmed-meshheading:15448205...lld:pubmed
pubmed-article:15448205pubmed:meshHeadingpubmed-meshheading:15448205...lld:pubmed
pubmed-article:15448205pubmed:meshHeadingpubmed-meshheading:15448205...lld:pubmed
pubmed-article:15448205pubmed:meshHeadingpubmed-meshheading:15448205...lld:pubmed
pubmed-article:15448205pubmed:meshHeadingpubmed-meshheading:15448205...lld:pubmed
pubmed-article:15448205pubmed:meshHeadingpubmed-meshheading:15448205...lld:pubmed
pubmed-article:15448205pubmed:meshHeadingpubmed-meshheading:15448205...lld:pubmed
pubmed-article:15448205pubmed:meshHeadingpubmed-meshheading:15448205...lld:pubmed
pubmed-article:15448205pubmed:meshHeadingpubmed-meshheading:15448205...lld:pubmed
pubmed-article:15448205pubmed:meshHeadingpubmed-meshheading:15448205...lld:pubmed
pubmed-article:15448205pubmed:meshHeadingpubmed-meshheading:15448205...lld:pubmed
pubmed-article:15448205pubmed:meshHeadingpubmed-meshheading:15448205...lld:pubmed
pubmed-article:15448205pubmed:meshHeadingpubmed-meshheading:15448205...lld:pubmed
pubmed-article:15448205pubmed:meshHeadingpubmed-meshheading:15448205...lld:pubmed
More...